Stockscreener 앱 받기
2.05
2.15%
-0.045
시간 외 거래:
2.40
0.35
+17.07%
전일 마감가:
$2.095
열려 있는:
$2.285
하루 거래량:
11,139
Relative Volume:
1.09
시가총액:
$16.39M
수익:
$85,000
순이익/손실:
$-22.16M
주가수익비율:
-0.0544
EPS:
-37.672
순현금흐름:
$-6.29M
1주 성능:
-15.46%
1개월 성능:
-50.99%
6개월 성능:
-78.12%
1년 성능:
-84.25%
1일 변동 폭
$2.04
$2.285
1주일 범위
$2.04
$2.50
52주 변동 폭
$2.04
$28.44
Pavmed Inc Stock (PAVM) Company Profile
명칭
Pavmed Inc
전화
(212) 949-4319
주소
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
2.05 | 16.39M | 85,000 | -22.16M | -6.29M | -37.67 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 개시 | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 개시 | Maxim Group | Buy |
Pavmed Inc 주식(PAVM)의 최신 뉴스
PAVmed subsidiary Lucid Diagnostics raises $15 million in preferred stock sale - Investing.com Canada
PAVmed Launches New At-the-Market Equity Offering - The Globe and Mail
PAVmed Launches New At-the-Market Equity Offering - TipRanks
(PAVM) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Q1 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
PAVmed Inc. Series Z Warrant (PAVMZ) Key Financial Ratios – Valuation, Profitability & More - Value Research
PAVmed Inc (PAVMW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026 - Eastern Progress
Completion of Louisville VA Medical Center delayed until 2027 - AOL.com
PAVmed (PAVM) Results Check: Profit Per Share Falls Below Its Benchmark under the Current Snapshot; Stock Move: Shares Finish 1.57% Up at the ClosePost-Earnings Reaction - vinanet.vn
WVU PCH updates their signage and navigation - AOL.com
VA touts psilocybin trial for vets, but relief could take time - AOL.com
Verasonics Appoints New Senior Vice President, Research & Development - AOL.com
PAVmed (PAVM) Results Check: Profit Per Share Falls Below Its Benchmark under the Current Snapshot; Stock Move: Shares Finish 1.57% Up at the CloseInvestor Earnings Call - dars.gov.et
PAVmed (PAVM) Report Card: The Available Earnings Metric Delivers a Miss at the Close; Post-Earnings Trading: The Stock Loses 4.98% in the Current UpdateProfitability Analysis - vinanet.vn
Former President of DePuy Synthes U.S. Joins Peptilogics Board - AOL.com
PAVmed (PAVM) Report Card: The Available Earnings Metric Delivers a Miss at the Close; Post-Earnings Trading: The Stock Loses 4.98% in the Current UpdateProfit Guidance Range - dars.gov.et
PAVmed Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PAVM) 2026-08-17 - Seeking Alpha
St. Joseph's Health Now Offers Pluvicto For Advanced Prostate Cancer - AOL.com
Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Maintains Target Price $16 - Moomoo
PAVmed Q2 2026 slides: loss narrows as device programs advance By Investing.com - Investing.com Nigeria
PAVmed Q2 2026 slides: loss narrows as cash position weakens By Investing.com - Investing.com Nigeria
PAVmed reports Q2 progress with Veris, Lucid, a... - Pluang
PAVmed (PAVM) Q2 2026 Earnings Call Transcript - The Globe and Mail
PAVmed Inc (PAVM) (Q2 2026) Earnings Call Highlights: Narrowing - GuruFocus
PAVmed Inc (PAVM) (Q2 2026) Earnings Call Highlights: Narrowing - GuruFocus
Pavmed Stock Price Forecast. Should You Buy PAVM? - StockInvest.us
PAVM Q1 2026 Earnings: EPS of -$4.42 Misses Consensus by 519%; Shares Rally 9.7%ROA Comparison - vinanet.vn
PAVmed Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
PAVM Q2 FY2026 earnings call - finance.biggo.com
PAVmed Q2 2026 slides: loss narrows as cash position weakens By Investing.com - Investing.com India
PAVM Looks 288.7% Overvalued on GF Value™ - GuruFocus
Is PAVmed Inc (PAVM) Overvalued After Q2 Earnings Miss? EPS at -$0.55, Revenue at $0.05M; GF Score: 32/100 - GuruFocus
Form 8K PAVmed Inc For: 14 August By Investing.com - Investing.com Nigeria
Form 8K PAVmed Inc For: 14 August By Investing.com - Investing.com Australia
PAVmed Q2 2026 slides: loss narrows as device programs advance By Investing.com - Investing.com Australia
Form 8K PAVmed Inc For: 14 August By Investing.com - Investing.com India
Form 8K PAVmed Inc For: 14 August By Investing.com - Investing.com Canada
Earnings call transcript: PAVmed narrows Q2 2026 loss as shares slip - Investing.com Australia
Earnings call transcript: PAVmed narrows Q2 2026 loss as shares slip - Investing.com Canada
PAVmed Q2 2026 slides: loss narrows as cash position weakens - Investing.com
PAVmed Q2 revenue jumps to $33k; $30m warrants issued - scanx.trade
Earnings call transcript: PAVmed narrows Q2 2026 loss as shares slip - Investing.com South Africa
PAVmed Q2 2026 slides: loss narrows as device programs advance - Investing.com
PAVM: Q2 saw operational progress, positive clinical results, and improved financial positioning - TradingView
Earnings call transcript: PAVmed narrows Q2 2026 loss as shares slip - Investing.com
PAVM: Net loss narrowed and operational progress advanced, with regulatory milestones on track - TradingView
PAVmed Q2 2026 Earnings Call: Complete Transcript - Benzinga
Q2 2026 PAVmed Inc Earnings Call Transcript - GuruFocus
Pavmed Inc (PAVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.76%
2.19%
자본화:
|
볼륨(24시간):